BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 15, 2009
View Archived Issues
FDA Review of Gout Drug Sends Savient Stock Soaring
Shares of Savient Pharmaceuticals Inc. skyrocketed 56 percent Friday after FDA drug reviewers said in briefing documents that the firm's gout drug Krystexxa (pegloticase) was effective. (BioWorld Today)
Read More
Oscient to Cut Sales Force as it Weighs Possible Sale
Read More
MicroRNA Replacement Via Gene Therapy Stops Liver Cancer Cold
Read More
Allergy Therapeutics Adding £22.4M, Getting New CEO
Read More
CDC Issues First Guidelines Governing Genetic Testing
Read More
CombinatoRx Shares Juiced by Synavive Data Breakdown
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Financings Roundup
Read More